<DOC>
	<DOCNO>NCT03026036</DOCNO>
	<brief_summary>This study investigate stress-related signal glutamate dopamine within reward-processing circuit Major Depressive Disorder ( MDD ) , whether use predict depressive symptom future . This achieve various neuroimaging tool ( MRS , fMRI , PET ) , behavioral task , naturalistic follow-up design .</brief_summary>
	<brief_title>Neuroimaging Studies Reward Processing Depression</brief_title>
	<detailed_description>The overarching goal research investigate : ( 1 ) stress-induced glutamatergic abnormality relation disruption within corticostriatal valuation circuit MDD ; ( 2 ) stress-induced DA signaling disruption MDD ; ( 3 ) predictive validity two pathophysiological mechanism . This achieve innovative integration ( 1 ) proton magnetic resonance spectroscopy ( MRS ) -based assessment glutamatergic metabolite mPFC ; ( 2 ) functional magnetic resonance imaging ( fMRI ) probe corticostriatal valuation circuit well-established stress manipulation ( MAST ) assessment ( cortisol inflammatory marker ) ; ( 3 ) positron emission tomography ( PET ) -based measurement striatal DA release well-established stress manipulation assessment ( cortisol inflammatory marker ) ; ( 4 ) naturalistic follow-up design .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<criteria>General All gender , race , ethnic origin , age 18 45 Capable provide write informed consent , fluent English Righthanded Absence psychotropic medication least 2 week Inclusion Criteria Current Depression Group ( MDD ) : Current DSM5 diagnostic criterion MDD ( diagnose use SCID ) Inclusion Criteria Remitted Depression Group ( rMDD ) : History least one major depressive episode within past five year Not currently depress Inclusion Criteria Healthy Control Group ( HC ) : Absence medical , neurological , psychiatric illness ( include alcohol/substance abuse ) Subjects suicidal ideation outpatient treatment determine unsafe study clinician Pregnant woman Failure meet standard MRI PET safety requirement Serious unstable medical illness History seizure disorder History current diagnosis organic mental disorder , schizophrenia , schizoaffective disorder , delusional disorder , psychotic disorder otherwise specify , bipolar disorder , OCD , PTSD , mood congruent mood incongruent psychotic feature , substance dependence , substance abuse within last 12 month ( exception cocaine stimulant abuse , lead automatic exclusion ) Simple phobia , social anxiety disorder , generalize anxiety disorder allow secondary MDD MDD group History cocaine stimulant use ( e.g. , amphetamine , cocaine , methamphetamine ) History use dopaminergic drug ( include methylphenidate ) Patients lifetime history electroconvulsive therapy ( ECT )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Depression</keyword>
	<keyword>MRI</keyword>
	<keyword>PET</keyword>
	<keyword>Reward</keyword>
</DOC>